NASDAQ: AAPG
Ascentage Pharma Group International Stock Ownership - Who owns Ascentage Pharma Group International?

Insider buying vs selling

Have Ascentage Pharma Group International insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when AAPG insiders and whales buy or sell their stock.

AAPG Shareholders

What type of owners hold Ascentage Pharma Group International stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Point72 Asset Management LP0.00%16,726$408.62kInstitution
Xy Capital Ltd0.00%13,628$332.93kInstitution
Citadel Advisors LLC0.00%9,737$237.87kInstitution
Ubs Group Ag0.00%4,232$103.39kInstitution
Mirae Asset Global Investments Co Ltd0.00%2,546$62.20kInstitution
Tower Research Capital LLC Trc0.00%230$5.62kInstitution
Osaic Holdings Inc0.00%220$5.37kInstitution
Bank Of America Corp0.00%201$4.91kInstitution
Morgan Stanley0.00%153$3.74kInstitution
Bell Investment Advisors Inc0.00%67$1.64kInstitution

1 of 2

AAPG vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AAPG0.01%0.00%
GLPG47.64%0.00%
SNDX91.46%8.54%Net SellingNet Selling
MLYS67.62%32.38%Net BuyingNet Selling
ZLAB2.62%1.77%Net BuyingNet Buying

Ascentage Pharma Group International Stock Ownership FAQ

Who owns Ascentage Pharma Group International?

Ascentage Pharma Group International (NASDAQ: AAPG) is owned by 0.01% institutional shareholders, 0.00% Ascentage Pharma Group International insiders, and 99.99% retail investors. Point72 Asset Management LP is the largest individual Ascentage Pharma Group International shareholder, owning 16,726.00 shares representing 0.00% of the company. Point72 Asset Management LP's Ascentage Pharma Group International shares are currently valued at $409.95k.

If you're new to stock investing, here's how to buy Ascentage Pharma Group International stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.